Genpharmasec Ltd — Board Meeting, 11-08-2026: Board Meeting
11-08-2026 | 04:02 pm
11-08-2026 | 04:02 pm
Genpharmasec's board approved the financial results for the quarter ended June 30, 2026. Standalone profit was ₹0.57 Cr. Consolidated results showed a loss of ₹0.07 Cr.
No comments yet. Be the first to comment!
